Top Markets
Coin of the day
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Rank in Stocks #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Share Price
$0.49606484
Last synced: 2026-08-21
Market Cap
$88.47M
Change (1 day)
-1.58%
Change (1 year)
-22.51%
Country
TW
Trade Intech Biopharm Corporation (6461)

Category

P/B ratio for Intech Biopharm Corporation (6461)
P/B ratio as of 2026 TTM: 0
According to Intech Biopharm Corporation latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Intech Biopharm Corporation from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH